Germany: Proposed regulation increasing transparency at the EFSA threatens IP

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Germany: Proposed regulation increasing transparency at the EFSA threatens IP

On December 11 2018 the European Parliament discussed the proposal for a regulation on the transparency and sustainability of EU risk assessment in the food chain amending, inter alia, Regulation (EC) No 178/2002 [General Food Law].

Public controversy regarding the use of genetically modified organisms and herbicide glyphosate paved the way for an initiative which entailed a legislative proposal by the European Commission (COM (2018)0179). The ensuing regulation will amend the EU's General Food Law Regulation.

On February 11 2019 the European Parliament and the European Council reached a provisional agreement on the EU Commission's Proposal.

At present, the transparency rules of the European Food Safety Association (EFSA) are not as harsh as those of the other agencies – the proposed regulation makes the authorisation procedure harsher than at other agencies. Other agencies (for instance, the European Medicines Agency) publish applications and studies at the time when they publish their opinion.

It is of central interest to the food industry what this proposed regulation requires of companies in terms of when the publication of information and underlying studies in relation to applications are due and which documents must be produced. In accordance with the proposed legislative text, food companies will need to inform the EFSA immediately of the subject matter of studies commissioned.

The revised regulation will entail automatic publication of all studies and information submitted to the EFSA to support the authorisation of a proposed product or ingredient. This data will be uploaded to the EFSA website early in the approval process.

Furthermore, the regulation will establish a database of studies for the EFSA to identify whether all relevant research on a substance is considered in evaluating market applications, and stakeholders and the general public should be involved in consultations and notify the EFSA of any potentially omitted information.

The suggestions presented by the Committee on the Environment, Public Health and Food Safety, for making the proposal more workable, including the requirement that the EFSA should set up a preliminary opinion first and studies and non-confidential information should be published afterwards, were not accepted.

Under the new suggested regulation (see http://europa.eu/rapid/press-release_IP-19-1030_en.htm for updates on the status), the applicant cannot prevent its innovative idea and know-how connected to a new product being presented on the website of the EFSA at the commencement of the application procedure so that any competitor has access to such documents.

Authorisation procedures at the EFSA take up to 59 months – a time period during which competitors in third countries outside the EU will have access to sensitive data while the European application procedure is carried out.

The fact that data and studies will not be published after a consultation period but right at the commencement of the procedure imposes a serious risk of idea and know-how piracy.

EU legislation applicable to the food industry is already considered as very transparent, and the proposal which received the agreement of the council and the commission raises concerns about efficient protection of proprietary information of agri-food companies within the EU.

In this approach, the protection of intellectual property rights comes second to a transparent risk assessment process and it remains unclear how companies are supposed to comply with the requirement to provide a justification for requesting non-publication of their confidential information.

grabow.jpg

Dr Gisela Grabow


Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbHElisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64 24info@maiwald.euwww.maiwald.eu

more from across site and SHARED ros bottom lb

More from across our site

Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
Gift this article